Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
13.85
+0.12 (0.87%)
Nov 4, 2025, 3:36 PM EST - Market open
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $964.63 million as of November 4, 2025. Its market cap has decreased by -13.02% in one year.
Market Cap
964.63M
Enterprise Value
1.40B
1-Year Change
-13.02%
Ranking
Category
Stock Price
$13.85
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $964.63M, an increase of 83.00%. That is a compound annual growth rate of 10.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 956.27M | 72.23% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | 935.68M | 22.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 786.46B |
| Johnson & Johnson | 454.42B |
| AbbVie | 380.71B |
| UnitedHealth Group | 302.41B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 213.93B |